comparemela.com

Page 2 - Julien Dormois News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Much Milder Than Feared : Philips Shares Soar 43% After US Sleep Apnea Settlement

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

SIEMENS HEALTHINEERS : Receives a Buy rating from Jefferies -March 27, 2024 at 09:05 am EDT

Already positive, the research from Jefferies and its analyst Julien Dormois still consider the stock as a Buy opportunity. The target price is still set at EUR 60.

Smith & Nephew plc (NYSE:SNN) Q4 2023 Earnings Call Transcript

Smith & Nephew plc (NYSE:SNN) Q4 2023 Earnings Call Transcript February 28, 2024 Smith & Nephew plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Deepak Nath: Good morning and welcome to the Smith & Nephew Q4 and Full Year ‘23 […]

Fresenius Shares Rise After Better-Than-Expected Results

SIEMENS HEALTHINEERS : Gets a Buy rating from Jefferies -February 01, 2024 at 03:25 am EST

In his latest research note, analyst Julien Dormois confirms his positive recommendation. The broker Jefferies is keeping its Buy rating. The target price is unchanged and still at EUR 60.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.